Table 2 Response outcomes . After 4... | American Society of Hematology

Table 2

Response outcomes

	After 4 cycles,* N = 35	Best response,† N = 42
Best response, n (%)
CR	1 (3)	1 (2)
VGPR	8 (23)	9 (21)
PR	9 (26)	13 (31)
MR	3 (9)	2 (5)
SD	2 (6)	11 (26)
POD	12 (34)	6 (14)
ORR, % (95% CI)	51 (0.34-0.69)	55 (0.39-0.70)

	After 4 cycles,* N = 35	Best response,† N = 42
Best response, n (%)
CR	1 (3)	1 (2)
VGPR	8 (23)	9 (21)
PR	9 (26)	13 (31)
MR	3 (9)	2 (5)
SD	2 (6)	11 (26)
POD	12 (34)	6 (14)
ORR, % (95% CI)	51 (0.34-0.69)	55 (0.39-0.70)

Primary endpoint in the per-protocol population.

Response-evaluable patients.